BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29387418)

  • 1. Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.
    Nagata Y; Hirayama A; Ikeda S; Shirahata A; Shoji F; Maruyama M; Kayano M; Bundo M; Hattori K; Yoshida S; Goto YI; Urakami K; Soga T; Ozaki K; Niida S
    Biomark Res; 2018; 6():5. PubMed ID: 29387418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus.
    Nagata Y; Bundo M; Sugiura S; Kamita M; Ono M; Hattori K; Yoshida S; Goto YI; Urakami K; Niida S
    Mol Med Rep; 2017 Sep; 16(3):3034-3040. PubMed ID: 28714010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Vanninen A; Lukkarinen H; Kokkola T; Koivisto AM; Kokki M; Musialowicz T; Hiltunen M; Zetterberg H; Leinonen V; Herukka SK; Rauramaa T
    J Alzheimers Dis; 2023; 94(2):727-736. PubMed ID: 37334597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cerebrospinal fluid space between probable normal pressure hydrocephalus and Alzheimer's disease.
    Li H; Liu C; Tai H; Wei Y; Shen T; Yang Q; Zheng K; Xing Y
    Front Aging Neurosci; 2023; 15():1241237. PubMed ID: 37693646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperdynamic CSF motion profiles found in idiopathic normal pressure hydrocephalus and Alzheimer's disease assessed by fluid mechanics derived from magnetic resonance images.
    Takizawa K; Matsumae M; Hayashi N; Hirayama A; Yatsushiro S; Kuroda K
    Fluids Barriers CNS; 2017 Oct; 14(1):29. PubMed ID: 29047355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid Alzheimer's Biomarkers and Neurofilament Light Profile of Idiopathic Normal Pressure Hydrocephalus in China: A PUMCH Cohort Study.
    Mao C; Sha L; Liu C; Chu S; Li J; Huang X; Lei D; Wang J; Dong L; Xu Q; Peng B; Cui LY; Gao J
    Neurodegener Dis; 2020; 20(5-6):165-172. PubMed ID: 34077945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CSF LRG and Decreased Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Vanninen A; Nakajima M; Miyajima M; Rauramaa T; Kokki M; Musialowicz T; Mäkinen PM; Herukka SK; Koivisto AM; Jääskeläinen JE; Hiltunen M; Leinonen V
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33800840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.
    Jurjević I; Miyajima M; Ogino I; Akiba C; Nakajima M; Kondo A; Kikkawa M; Kanai M; Hattori N; Arai H
    J Alzheimers Dis; 2017; 56(1):317-325. PubMed ID: 27911315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct volumetric features of cerebrospinal fluid distribution in idiopathic normal-pressure hydrocephalus and Alzheimer's disease.
    Han J; Kim MN; Lee HW; Jeong SY; Lee SW; Yoon U; Kang K
    Fluids Barriers CNS; 2022 Sep; 19(1):66. PubMed ID: 36045420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid shunt surgery reduces the risk of developing dementia and Alzheimer's disease in patients with idiopathic normal pressure hydrocephalus: a nationwide population-based propensity-weighted cohort study.
    Tseng PH; Huang WT; Wang JH; Huang BR; Huang HY; Tsai ST
    Fluids Barriers CNS; 2024 Feb; 21(1):16. PubMed ID: 38355601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.
    Weiner S; Junkkari A; Sauer M; Luikku A; Rauramaa T; Kokkola T; Herukka SK; Blennow K; Zetterberg H; Leinonen V; Gobom J
    Fluids Barriers CNS; 2023 Jun; 20(1):40. PubMed ID: 37277809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases.
    Braun M; Boström G; Ingelsson M; Kilander L; Löwenmark M; Nyholm D; Burman J; Niemelä V; Freyhult E; Kultima K; Virhammar J
    Fluids Barriers CNS; 2023 Oct; 20(1):72. PubMed ID: 37833765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus.
    Schirinzi T; Sancesario GM; Ialongo C; Imbriani P; Madeo G; Toniolo S; Martorana A; Pisani A
    Front Neurol; 2015; 6():86. PubMed ID: 25954245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Kawamura K; Miyajima M; Nakajima M; Kanai M; Motoi Y; Nojiri S; Akiba C; Ogino I; Xu H; Kamohara C; Yamada S; Karagiozov K; Ikeuchi T; Kondo A; Arai H
    J Alzheimers Dis; 2021; 83(1):179-190. PubMed ID: 34275898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.